Wingate Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$680K Hold
567
0.3% 64
2026
Q1
$522K Sell
567
-4
-0.7% -$4.05K 0.28% 69
2025
Q4
$614K Sell
571
-5
-0.9% -$4.78K 0.34% 65
2025
Q3
$439K Buy
576
+26
+5% +$19.3K 0.3% 70
2025
Q2
$429K Buy
550
+243
+79% +$189K 0.38% 66
2025
Q1
$254K Hold
307
0.29% 82
2024
Q4
$237K Buy
+307
New +$254K 0.23% 85

Other funds holding LLY

Wingate Wealth Advisors's LLY Position: Q2 2026 in Review

Wingate Wealth Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 567 shares worth $680K. The position accounts for 0.3% of the portfolio, ranked #64.

Wingate Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Wingate Wealth Advisors held 567 shares of Eli Lilly worth $680K as of Q2 2026.
  • Wingate Wealth Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.3% of Wingate Wealth Advisors's portfolio in Q2 2026, its #64 holding.
  • Wingate Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Wingate Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.